Solventum Corp | SOLV - Cash And Equivalent


Solventum Corp reported $1.64B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Cencora USD 1.75B 2.6B Dec/2025
Dexcom USD 917.7M 918M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
West Pharmaceutical Services USD 791.3M 162.8M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025